Latest News

August 31, 2017

Analgesic Solutions to Present Posters at PAINWeek 2017 in Las Vegas September 5-9

By asoladmin In Uncategorized with Comments Off on Analgesic Solutions to Present Posters at PAINWeek 2017 in Las Vegas September 5-9

 

Analgesic Solutions will present proprietary tools and research posters at the 11th Annual PAINWeek Conference in Las Vegas, NV on September 5-9. PAINWeek is the largest US pain conference for frontline clinicians with an interest in pain management.

We invite you to meet our team presenting the following research posters. If you would like to schedule a meeting or would like to learn more about the information being presenting at PAINWeek, please contact Tony May at tmay@analgesicsolutions.com or 781-444-9605 x120.


Poster Presentations

Thursday, September 7
6:30-8:30 pm

  • Title: “A Review of Measures Assessing Opioid-sparing Effects of Analgesics in Patients with Chronic Non-Cancer Pain”

Authors: Maitreyee Mohanty, Ryan Lanier, Nathalie Erpelding, Dolapo Lawal, and Nathaniel Katz

Presenter: Maitreyee Mohanty, PhD, Consultant, Real World Evidence

  • Title: “Accurate Pain Reporting Training Improved Subject Pain Reporting and Treatment Discrimination Performance in a Randomized Placebo-Controlled Study of Pregabalin Versus Placebo in Painful Diabetic Neuropathy”

Authors: Roi Treister, Dolapo Lawal, Jay Trudeau, John Bothmer, Mark Field, Stephen Wright, Nathalie Erpelding, and Nathaniel Katz

Presenter: Nathalie Erpelding, PhD, Director of R & D

  • Title: “Development, Feasibility, and Implementation of the Misuse, Abuse, and Diversion Drug Event Reporting System (MADDERS®) for Assessing and Classifying Misuse and Abuse-Related Events in Clinical Trials”

Authors: Ryan Lanier, Harrison Elder, Roi Treister, Maitreyee Mohanty, Nathalie Erpelding, Dolapo Lawal, and Nathaniel P Katz

Presenter: Ryan K. Lanier, PhD, Senior Consultant, Drug Development

  • Title: “Implementation of the Misuse, Abuse, and Diversion Drug Event Reporting System (MADDERS®) to Evaluate Potentially Abuse-Related Events in Phase III Clinical Trials of Sativex® Oromucosal Spray for the Treatment of Cancer Pain”

Authors: Ryan Lanier, Harrison Elder, Roi Treister, Maitreyee Mohanty, Nathalie Erpelding, Dolapo Lawal, Matthew Hersch, Tilden Etges, Nathaniel P Katz

Presenter: Ryan K. Lanier, PhD, Senior Consultant, Drug Development


Analgesic Solutions, LLC, founded in 2006, is a privately held company focused on increasing assay sensitivity in the conduct of pain clinical trials through consulting, innovative tools and technology, and training. Our team, with Nathaniel Katz M.D., M.S., serving as our foremost expert, helps clients develop and commercialize better treatments for pain. With hundreds of projects completed and ongoing collaborations with regulatory authorities, Analgesic Solutions is the expert at identifying and mitigating the random and systematic errors that lead to negative clinical trials.

Scroll to top